反応式
Br[C:2]1[S:3][C:4]2[C:9]([Cl:10])=[N:8][C:7]([S:11][CH2:12][C:13]3[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=3)=[N:6][C:5]=2[N:19]=1.[CH3:20][NH2:21]>O1CCCC1>[Cl:10][C:9]1[C:4]2[S:3][C:2]([NH:21][CH3:20])=[N:19][C:5]=2[N:6]=[C:7]([S:11][CH2:12][C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)[N:8]=1参加物
4
実験手順
A solution of the product from Example 219 (0.3 g) in tetrahydrofuran (2 ml) containing methylamine (2.0 molar in THF: 0.81 ml) was stirred for 16 hours. The mixture was evaporated to dryness then purified (SiO2, ethyl acetate:dichloromethane 1:9 as eluant) to give the title compound (295 mg).
後処理
- customThe mixture was evaporated to dryness
- customthen purified (SiO2, ethyl acetate:dichloromethane 1:9 as eluant)
出典と根拠
- ORDレコード
- ord-b015c6be86a4456390b77af240e36bd0
- 出典データセット
- uspto-grants-2004_10
- 特許番号
- US06806273B1
関連ノート
読み込み中…